Gilde Healthcare sells NightBalance to Royal Philips

Philips will expand its sleep and respiratory care portfolio through the acquisition.

Philips' health technology portfolio generated sales of €17.8bn in 2017 and employs approximately 74,000 people.

Previous funding
Thuja Capital and the Health Innovation Fund provided NightBalance with its first round of financing in April 2011. The VC firm took part again in July 2013, when Van Herk Investments led a series-A round at an undisclosed valuation.

Finally, Gilde Healthcare led a €12.5m series-B for the company in July 2016 alongside Inkef Capital.

Company
Founded in 2009 and headquartered in Delft, the Netherlands, NightBalance develops and markets the Sleep Position Trainer (SPT), a device to prevent positional obstructive sleep apnea. CE-marked since 2012, the SPT is currently sold in 11 European countries.

People
Gilde Healthcare – Pieter van der Meer (partner).
NightBalance – Eline Vrijland-van Beest (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Benelux
• Healthcare
• Trade sale
• Netherlands
• Gilde Investment Management